Dynamic Learning in Depression

June 15, 2020 updated by: University of Oxford
This study will assess learning bias (the tendency to learn more from negative relative to positive outcomes) at baseline in 3 groups of participants (currently depressed, previously depressed and never depressed). It will then try to modify this bias using a simple computerised training task completed at home daily for 2 weeks. Outcome measures include symptoms of depression, cognitive measures (i.e. accuracy and reaction time during completion of tasks), pupillometry measures and salivary cortisol.

Study Overview

Status

Completed

Conditions

Detailed Description

Depressed patients tend to focus on negative, at the expense of positive, events. This bias of attention is thought to be one factor which causes some people to be at higher risk of developing depression. One reason depressed people might pay more attention to negative events is that they think those events are more useful to them when they learn about the future. In this study the investigators will compare the learning styles (i.e. whether participants focus more on negative or positive information when learning about the future), cognitive biases and salivary cortisol levels (the levels of the hormone cortisol can be measured in the saliva and is known to be raised in those at risk of depression) of currently depressed (N=40), previously depressed (N=40) and never depressed (N=40) participants. The study will then randomly assign participants to complete one of two version of a learning task daily over two weeks. One version of the task will be designed to encourage an optimistic learning style, whereas the other will encourage neither an optimistic nor pessimistic learning style. The study will then retest participants' learning styles, cognitive biases, salivary cortisol and mood (using questionnaire measures) after completion of the task and again after 1 month. Study activities for participants will be: Screening visit (1 hours), baseline test visit (2 hours), task completion at home (10 mins per day for 2 weeks), test visit 2 (2 hours, completed 2 weeks after baseline visit) and test visit 3 (2 hours, completed 1 month after test visit 2). Participants will be asked to collect saliva samples, to measure cortisol, immediately after they wake up on the 3 testing days. Note that testing sessions involve pupillometry (measurement of area of pupil of the eye). This is done using a specialised camera pointed at the eye and is not invasive.

Study Type

Interventional

Enrollment (Actual)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Oxfordshire
      • Oxford, Oxfordshire, United Kingdom, OX3 7JX
        • Dept of Psychiatry, University of Oxford

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Participant is willing and able to give informed consent for participation in the study.
  • Male or Female, aged 18 to 60 years.
  • Fluent in English.
  • Not currently taking any psychoactive medications (except hormone contraceptives).
  • Currently meets SCID (Structured Clinical Interview for Diagnosis:DSMV) criteria for MDD--Major Depressive Disorder-- (currently depressed group only).
  • Meets SCID criteria for 2 or more previous episodes of MDD, has been in remission for at least 3 months (previously depressed group only).
  • No previous or current axis I diagnosis (control group only).

Exclusion Criteria:

  • Previous or current diagnosis of bipolar disorder or psychotic illness.
  • Previous or current anxiety disorder (control group only, anxiety disorder is permitted in current and previously depressed group as long as primary diagnosis of MDD (current or previous) is present).
  • Significant suicidal ideation.
  • Use of drug of abuse within the last 3 months.
  • Receiving treatment (either pharmacological or psychological) for psychiatric condition.
  • Medical or surgical treatment which prevents dilation/constriction of pupil.
  • Prior experience of the tasks used in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: IBLT (information bias learning task)
Computerised task in which most information is provided by positive outcomes. Completed for 10 mins per day every day for 2 weeks.
Information bias learning task-- a computer based task in which positive information is more useful when learning how best to complete it
Placebo Comparator: IBLT control
Computerised task in which information is provided by both positive and negative outcomes. Completed 10 mins per day every day for 2 weeks
A control version of the IBLT task-- a computer based task in which both positive and negative information is useful when learning how to complete it

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quick Inventory of Depressive Symptoms (self report, 16 item)
Time Frame: change between baseline and week 6
Standard questionnaire measure of depressive symptoms
change between baseline and week 6

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quick Inventory of Depressive Symptoms (self report, 16 item)
Time Frame: change between baseline and week 2
standard questionnaire measure of depressive symptoms
change between baseline and week 2
Montgomery Asberg Depression Rating Scale
Time Frame: change from baseline to week 2 and 6
Standard clinical rating scale for depression
change from baseline to week 2 and 6
Learning parameters from information bias assessment task
Time Frame: baseline to weeks 2 and 6
Derived parameters from a computer based learning task (tests process presumed to be altered by IBLT-- information bias learning task-- intervention)
baseline to weeks 2 and 6
Salivary cortisol concentration
Time Frame: baseline to weeks 2 and 6
Samples collected on waking
baseline to weeks 2 and 6
Learning parameters derived from pupillometry data
Time Frame: baseline to weeks 2 and 6
Parameters are derived from regression of pupil size data collected during the information bias assessment task
baseline to weeks 2 and 6

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Speilberger State and Trait Anxiety Inventory
Time Frame: Baseline to weeks 2 and 6
standard questionnaire measure of state and trait anxiety
Baseline to weeks 2 and 6
Depressive Attributes Questionnaire
Time Frame: baseline to weeks 2 and 6
Questionnaire assessing attribution bias in depression
baseline to weeks 2 and 6
Rumination Response Scale
Time Frame: baseline to weeks 2 and 6
Questionnaire assessing tendency to ruminate
baseline to weeks 2 and 6
Snaith-Hamilton Pleasures Scale
Time Frame: Baseline to weeks 2 and 6
Questionnaire assessing anhedonia
Baseline to weeks 2 and 6
Accuracy and reaction time during computerised cognitive tasks
Time Frame: baseline to weeks 2 and 6
Scores are derived from computer based tasks assessing emotional perception and learning
baseline to weeks 2 and 6

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Michael Browning, MB.BS, University of Oxford

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2016

Primary Completion (Actual)

June 3, 2020

Study Completion (Actual)

June 3, 2020

Study Registration Dates

First Submitted

September 22, 2016

First Submitted That Met QC Criteria

September 22, 2016

First Posted (Estimate)

September 26, 2016

Study Record Updates

Last Update Posted (Actual)

June 16, 2020

Last Update Submitted That Met QC Criteria

June 15, 2020

Last Verified

April 1, 2019

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • Dynamic Learning in Depression

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Anonymised data will be shared with researchers who contact the PI after study completion.

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Subscribe